Tesofensine structure and classification Chemical identity: Small molecule drug (not a peptide ) Chemical name: (1R,2S)-2-(3,4-dichlorophenyl)cyclopropyl]methylamine Molecular weight: 216.11 g/mol Synthetic compound (not naturally occurring) Originally code-named NS2330 Why called "tesofensine": Generic pharmaceutical name Developed by NeuroSearch (Danish company) Initially for neurological conditions Repurposed for obesity after accidental discovery Now primarily researched for weight loss Drug classification: Triple monoamine reuptake inhibitor (TRI) Affects: Dopamine, norepinephrine, serotonin Similar mechanism to ADHD medications CNS stimulant properties Schedule classification: Unscheduled but controlled Not a peptide - why included here: Often grouped with weight loss peptides Compared to semaglutide and tirzepatide Sold by peptide vendors Used in weight loss stacks Similar goals as weight loss peptides Learn about what peptides are and how they work at SeekPeptides
In the acute phase, symptoms include euphoria, anxiety, paranoia, and psychomotor agitation, which are primarily caused by the short-term overactivation of neurotransmitter systems (McCann et al., 2008)
Behavioral approaches can also address habits and triggers without adding a new substance
Take the missed dose as soon as you remember, then resume your normal weekly schedule
Relevance of brown adipose tissue in infancy and adolescence
Immediately replace the needle cap (if you need to recap otherwise do not recap by hand) and discard the syringe in a designated sharps container
